Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Somebody Obviously Trying to Keep Price Do

<< Previous

Bullboard Posts

Next >>

Comment by The300on May 28, 2011 9:41am

321 Views

Post# 18638910

RE: RE: Somebody Obviously Trying to Keep Price Do

Hey manstar,

I've looked at SEDI and CanadianInsider.com and don't see anything new or of interest.

I can't imagine that you are referring to the Hudbay private placement from several months ago because that is old news.

If Hudbay were accumulating, they would have to report it on SEDI as they are considered an insider controlling more than 10% of the stock. I checked recently and there is no accumulation taking place by any insiders.

I'd love to hear some good news, but I don't see anything. If I've missed something, please share the source and link with all of us here.

Thanks

The 300

<< Previous

Bullboard Posts

Next >>

This battery metals stock is on a path to the global stage